BRPI0404861B8 - method of extracting secretory immunoglobulin (follow) from breast milk and human colostrum and its clinical use orally - Google Patents
method of extracting secretory immunoglobulin (follow) from breast milk and human colostrum and its clinical use orallyInfo
- Publication number
- BRPI0404861B8 BRPI0404861B8 BRPI0404861A BRPI0404861A BRPI0404861B8 BR PI0404861 B8 BRPI0404861 B8 BR PI0404861B8 BR PI0404861 A BRPI0404861 A BR PI0404861A BR PI0404861 A BRPI0404861 A BR PI0404861A BR PI0404861 B8 BRPI0404861 B8 BR PI0404861B8
- Authority
- BR
- Brazil
- Prior art keywords
- follow
- breast milk
- human
- colostrum
- extracting
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
método de extração da imunoglobulina a secretória (siga) a partir do leite materno e colostro humano e seu uso clínico por via oral. a presente invenção refere-se a obtenção da imunoglobulina a secretória (siga) extraída à partir do leite materno humano e do colostro humano, para administração via oral com indicações clínicas para casos de imunodeficiência primárias ou secundárias, imunossupressão, intoxicações, infecções por microorganismos toxigênicos ou patogênicos, além de prematuros e recém-natos com peso muito baixo visando conferir a imunização passiva a estes indivíduos; métodos de extração da siga de um 'pool' de leite materno humano e de colostro armazenados em banco de leite humano (blh); testes de reatividade da siga obtida de um 'pool' de leite materno humano e de colostro armazenados em banco de leite humano (blh).method of extracting secretory immunoglobulin a (follow) from human breast milk and colostrum and its clinical use orally. The present invention relates to obtaining secretory immunoglobulin (follow) extracted from human breast milk and human colostrum, for oral administration with clinical indications for cases of primary or secondary immunodeficiency, immunosuppression, intoxications, infections by toxigenic microorganisms or pathogenic, in addition to preterm and very low birth weight newborns, aiming at providing passive immunization to these individuals; methods of extracting the tail from a pool of human breast milk and colostrum stored in a human milk bank (blh); Follow reactivity tests obtained from a pool of human breast milk and colostrum stored in a human milk bank (blh).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0404861A BRPI0404861B8 (en) | 2004-11-05 | 2004-11-05 | method of extracting secretory immunoglobulin (follow) from breast milk and human colostrum and its clinical use orally |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0404861A BRPI0404861B8 (en) | 2004-11-05 | 2004-11-05 | method of extracting secretory immunoglobulin (follow) from breast milk and human colostrum and its clinical use orally |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0404861A BRPI0404861A (en) | 2006-06-13 |
BRPI0404861B1 BRPI0404861B1 (en) | 2020-02-27 |
BRPI0404861B8 true BRPI0404861B8 (en) | 2021-05-25 |
Family
ID=36576133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0404861A BRPI0404861B8 (en) | 2004-11-05 | 2004-11-05 | method of extracting secretory immunoglobulin (follow) from breast milk and human colostrum and its clinical use orally |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0404861B8 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018227285A1 (en) * | 2017-06-13 | 2018-12-20 | Mane Viraj | Stable pooled breastmilk antibodies for oral delivery |
-
2004
- 2004-11-05 BR BRPI0404861A patent/BRPI0404861B8/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BRPI0404861A (en) | 2006-06-13 |
BRPI0404861B1 (en) | 2020-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gamra et al. | The potential use of 29 kDa protein as a marker of pathogenicity and diagnosis of symptomatic infections with Blastocystis hominis | |
Jin et al. | Serodiagnosis of echinococcosis by ELISA using cystic fluid from Uzbekistan sheep | |
Finzi et al. | Zinc treatment of outpatient COVID‐19: A retrospective review of 28 consecutive patients | |
Konstantinidis et al. | Olfactory dysfunction after coronavirus disease 2019 (COVID‐19) vaccination | |
Sadallah et al. | Production of specific monoclonal antibodies to Salmonella typhi flagellin and possible application to immunodiagnosis of typhoid fever | |
Papa et al. | Hantaviruses in Serbia and Montenegro | |
Kumar et al. | Facial Diplegia with Paresthesia: An Uncommon Variant of Guillain–Barre Syndrome | |
BRPI0404861B8 (en) | method of extracting secretory immunoglobulin (follow) from breast milk and human colostrum and its clinical use orally | |
Chaudhuri et al. | First documented case of imported tick‐borne encephalitis in A ustralia | |
Shahrokhabadi et al. | Seroepidemiological study of human hydatidosis in Rafsanjan, Kerman | |
Marrero et al. | Posthematopoietic stem cell transplant COVID‐19 infection in a pediatric patient with IPEX syndrome | |
Gheibi et al. | Severe anemia and Helicobacter pylori infection in school age children; a case reports | |
Kadkhoda et al. | Case Report: A case of colorado tick fever acquired in Southwestern Saskatchewan | |
Barrios et al. | Nephrotic syndrome with a nephritic component associated with toxoplasmosis in an immunocompetent young man. | |
Martini et al. | Edoardo Maragliano (1849-1940) and the immunogenicity of the tubercle bacillus: the pathway of a great italian physician | |
Verma et al. | Case report on typhoid fever | |
Miljković-Selimović et al. | Enteritis caused by Campylobacter jejuni followed by acute motor axonal neuropathy: a case report | |
Meena et al. | Osteomyelitis of scapula with secondary septic arthritis of shoulder joint in a six month old child | |
Park et al. | The 10 kDa protein of Taenia solium metacestodes shows genus specific antigenicity | |
Piña-Rosales et al. | Guillain-Barré Syndrome in an Immunocompromised Patient: A Case Report | |
Azizi | History of contemporary medicine: A brief history of smallpox eradication in Iran | |
Lokominaitė et al. | Psychosis as an Isolated Manifestation of COVID-19 in Non-Demented Patients with Parkinson's Disease: Clinical Cases and Literature Review | |
Pancer et al. | TBE in Poland | |
Ramachandran | HIV infection and maternal and child health | |
Peetermans et al. | Tropical sprue after travel to Tanzania |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/20 , A61K 39/395 , A61P 37/04 Ipc: C07K 16/04 (2006.01), A61K 39/395 (2006.01), A61P |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15V | Prolongation of time limit allowed | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/02/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/11/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |